Predicting the Efficacy of Immune-Based Therapies for Pediatric Solid Tumors
Predicting the Efficacy of Immune-Based Therapies for Pediatric Solid Tumors https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Jeb Phillips https://pediatricsnationwide.org/wp-content/uploads/2021/03/Jeb-Phillips.jpgExpression of HLA class I and β-2-microglobulin may show how susceptible some cancers are to T-cell based immunotherapies. A number of possible immunotherapies for cancer are based on T-cells that can target and kill tumors. These cytotoxic T lymphocytes (CTLs) can only recognize tumor…
read more